| Year |
Title |
Altmetric |
| 2019
|
CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses
2019
|
|
| 2019
|
Distinct roles for Peyer's patch B cells for induction of antigen-specific IgA antibody responses in mice administered oral recombinant Salmonella
2019
|
|
| 2019
|
Route of vaccine administration influences the impact of Fms-like tyrosine kinase 3 ligand (Flt3L) on chlamydial-specific protective immune responses
2019
|
|
| 2018
|
Transcutaneous immunization with pneumococcal surface protein A in mice
2018
|
|
| 2017
|
Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae
2017
|
|
| 2017
|
Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice
2017
|
|
| 2017
|
Rejuvenation of mucosal immunosenescence by adipose tissue-derived mesenchymal stem cells
2017
|
|
| 2016
|
The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin
2016
|
|
| 2016
|
Adipose-derived mesenchymal stem cells restore impaired mucosal immune responses in aged mice
2016
|
|
| 2015
|
Past efforts and future prospects for a nasal influenza vaccine
2015
|
|
| 2015
|
A molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderly.
2015
|
|
| 2015
|
Mucosal Immunosenescence in the Gastrointestinal Tract: A Mini-Review
2015
|
|
| 2015
|
Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques
2015
|
|
| 2014
|
A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "antigen Capsid-Incorporation" strategy
2014
|
|
| 2014
|
Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media
2014
|
|
| 2014
|
Mucosal adjuvants for vaccines to control upper respiratory infections in the elderly
2014
|
|
| 2013
|
Potential Roles of CCR5+ CCR6+ Dendritic Cells Induced by Nasal Ovalbumin plus Flt3 Ligand Expressing Adenovirus for Mucosal IgA Responses
2013
|
|
| 2012
|
oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza a virus
2012
|
|
| 2012
|
Inside the Mucosal Immune System
2012
|
|
| 2012
|
Novel vaccine development strategies for inducing mucosal immunity
2012
|
|
| 2012
|
Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type responses
2012
|
|
| 2012
|
A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging
2012
|
|
| 2012
|
Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection
2012
|
|
| 2011
|
Functional transforming growth factor-β receptor type ii expression by cd4 + t cells in peyer's patches is essential for oral tolerance induction
2011
|
|
| 2011
|
Oral-nasopharyngeal dendritic cells mediate T cell-independent IgA class switching on B-1 B cells
2011
|
|
| 2011
|
Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination
2011
|
|
| 2011
|
Elicitation of mucosal immunity by proteins of streptococcus pneumoniae
2011
|
|
| 2011
|
The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia
2011
|
|
| 2011
|
Induction of IL-10-producing CD4+ T-cells in chronic periodontitis
2011
|
|
| 2011
|
A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice
2011
|
|
| 2010
|
Mucosal regulatory cells in the gastrointestinal tract and periodontium
2010
|
|
| 2010
|
Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus
2010
|
|
| 2010
|
Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae
2010
|
|
| 2010
|
Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis
2010
|
|
| 2010
|
Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide
2010
|
|
| 2010
|
Oral immunization with Porphyromonas gingivalis outer membrane protein and CpG oligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity
2010
|
|
| 2009
|
A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota
2009
|
|
| 2009
|
Id2-, RORγt-, and LTβR-independent initiation of lymphoid organogenesis in ocular immunity
2009
|
|
| 2009
|
Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity
2009
|
|
| 2009
|
Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines
2009
|
|
| 2009
|
Co-administration of cholera toxin and apple polyphenol extract as a novel and safe mucosal adjuvant strategy
2009
|
|
| 2009
|
Mucosal immunosenescence: new developments and vaccines to control infectious diseases
2009
|
|
| 2008
|
Preferential use of DH reading frame 2 alters B cell development and antigen-specific antibody production
2008
|
|
| 2008
|
A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity
2008
|
|
| 2008
|
Double DNA adjuvant as the new generation immunostimulator in mucosal immune response
2008
|
|
| 2008
|
Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein σ1
2008
|
|
| 2008
|
Mucosal CD11b+DCs were Increased in PIRB Knockout Mice
2008
|
|
| 2008
|
Nasal Cholera Toxin Up-regulates Mucosal DCs And B1 B Cells Interactions For The Induction Of Innate IgA CSR.
2008
|
|
| 2008
|
A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration
2008
|
|
| 2008
|
Ovalbumin-Protein σ1 M-Cell Targeting Facilitates Oral Tolerance With Reduction of Antigen-Specific CD4+ T Cells
2008
|
|
| 2007
|
Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine
2007
|
|
| 2007
|
A single intranasal immunization with inactivated influenza virus and α-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system
2007
|
|
| 2007
|
Nasal cholera toxin elicits IL-5 anel IL-5 receptor α-chain expressing B-1a B cells for innate mucosal IgA antibody responses
2007
|
|
| 2007
|
Mucosal vaccine development for botulinum intoxication
2007
|
|
| 2007
|
Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Aβ1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/ Hu APPswe PS1dE9 mouse model of Alzheimer's disease
2007
|
|
| 2006
|
Type 1 and 2 T helper cell-mediated colitis
2006
|
|
| 2006
|
Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A
2006
|
|
| 2006
|
A second generation of double mutant cholera toxin adjuvants: Enhanced immunity without intracellular trafficking
2006
|
|
| 2006
|
Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production
2006
|
|
| 2006
|
A novel method for delivery of regulatory molecules in the GI tract using Bacillus anthracis protective antigen
2006
|
|
| 2006
|
Bacillus anthracis edema toxin acts as an adjuvant for enhanced immunity to PA and to unrelated vaccine antigens co-administered by the nasal or the transcutaneous route
2006
|
|
| 2006
|
Development and characterization of salivary IL-7 transgenic mice
2006
|
|
| 2006
|
Enhanced mucosal IgA ab responses in PIR-B knockout mice
2006
|
|
| 2006
|
Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens
2006
|
|
| 2005
|
Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract
2005
|
|
| 2005
|
Primary adenovirus-specific cytotoxic T lymphocyte response occurs after viral clearance and liver enzyme elevation
2005
|
|
| 2005
|
Nasal IL-12p70 DNA prevents and treats intestinal allergic diarrhea
2005
|
|
| 2005
|
Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract
2005
|
|
| 2005
|
Nasal Toll-like receptor 5 ligand elicits dendritic cell-mediated mucosal and systemic immune responses
2005
|
|
| 2005
|
A novel neurotoxoid vaccine prevents mucosal botulism
2005
|
|
| 2004
|
A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates
2004
|
|
| 2004
|
Role of gut-associated lymphoreticular tissues in antigen-specific intestinal IgA immunity
2004
|
|
| 2004
|
The role of CDR3 diversity restriction in mucosal and systemeic antibody responses following oral immuniation with r-Salmonella expressing tetanus toxin
2004
|
|
| 2004
|
Nasal Flt3 Ligand cDNA Elicits CD11c+ CD8+ Dendritic Cells for Enhanced Mucosal Immunity
2004
|
|
| 2004
|
CD4+CD45RBHi interleukin-4 defective T cells elicit antral gastritis and duodenitis
2004
|
|
| 2004
|
Mucosal immunity and tolerance in the elderly
2004
|
|
| 2004
|
Pathological Role of Large Intestinal IL-12p40 for the induction of Th2-Type Allergic Diarrhea
2004
|
|
| 2003
|
Cholera toxin activates dendritic cells through dependence on MG1-ganglioside which is mediated by NF-κB translocation
2003
|
|
| 2003
|
Therapeutic manipulation of the immune system: Enhancement of innate and adaptive mucosal immunity
2003
|
|
| 2003
|
Effective mucosal immunity to anthrax: Neutralizing antibodies and Th cell responses following nasal immunization with protective antigen
2003
|
|
| 2003
|
Nasal cholera toxin enhances innate mucosal immune responses.
2003
|
|
| 2003
|
Preferential induction of TLR4 expression on gamma 8 T-cells of submandibular glands.
2003
|
|
| 2003
|
An interconnected gut-associated lymphoreticular cell and tissue network for antigen-specific intestinal IgA immunity
2003
|
|
| 2003
|
Cholera toxin and heat-labile enterotoxin induce dendritic cell differentiation and prime immunity: differential requirement of glycolipid receptors
2003
|
|
| 2003
|
Nasal Flt3 ligand plasmid induces antigen-specific immune responses by mucosal dendritic cell recruitment
2003
|
|
| 2003
|
Neutralizing antibodies and T helper cell responses following nasal immunization with anthrax protective antigen
2003
|
|
| 2003
|
Oral live r-Salmonella expressing fragment C of tetanus toxin induces antigen-specific IgA responses in mice with limited IgH variable region diversity
2003
|
|
| 2003
|
TH1 dependent selection of the mucosal IgA repertoire is unable to overcome the contribution of an altered germline repertoire
2003
|
|
| 2003
|
Cholera toxin adjuvanticity is dependent upon Gm1-mediated NF-κB translocation and activation of dendritic cells
2003
|
|
| 2003
|
T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice
2003
|
|
| 2003
|
Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue
2003
|
|
| 2003
|
Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions
2003
|
|
| 2003
|
Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit
2003
|
|
| 2002
|
Quantitation of T-cell cytokine responses by ELISA, ELISPOT, flow cytometry and reverse transcriptase-PCR methods
2002
|
|
| 2002
|
A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced ige antibodies
2002
|
|
| 2002
|
A dilemma for mucosal vaccination: Efficacy versus toxicity using enterotoxin-based adjuvants
2002
|
|
| 2002
|
An antigen specific colitis model: TNBS (trinitrobenzene sulfonic acid) colitis without EtOH using adoptive T cell transfer
2002
|
|
| 2002
|
Small intestinal transformation and wasting disease induced in T cell deficient mice by adoptive transfer of CD45RB(Hi) Th2 cells
2002
|
|
| 2002
|
Effects of Self-Etching Primer, Adhesive, NaOCl and H_2O_2 on Lymphocytes : In Vitro Model
2002
|
|
| 2001
|
Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin
2001
|
|
| 2001
|
Resistance of T-cell receptor δ-chain-deficient mice to experimental Candida albicans vaginitis
2001
|
|
| 2001
|
The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation
2001
|
|
| 2001
|
A revisit of mucosal IgA immunity and oral tolerance
2001
|
|
| 2001
|
Elimination of colonic patches with lymphotoxin β receptor-Ig prevents TH2 cell-type colitis
2001
|
|
| 2001
|
Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis
2001
|
|
| 2001
|
Role of mucosal antibodies in viral infections
2001
|
|
| 2001
|
A revisit of the hapten-induced colitis model: Adoptive T cell transfer studies.
2001
|
|
| 2001
|
LPS-induced salivary innate and adaptive immunity in aged mice
2001
|
|
| 2001
|
Peyer's patches are required for oral tolerance to proteins
2001
|
|
| 2001
|
A role for Peyer's patches in oral tolerance to proteins
2001
|
|
| 2001
|
Alphavirus based HIV DNA vaccines delivered to mucosal surfaces
2001
|
|
| 2001
|
Alterations in the mucosal immune system during normal pregnancy and lactation
2001
|
|
| 2001
|
Dysfunctional Peyer's patches in aged mice impair oral tolerance induction
2001
|
|
| 2001
|
Impaired mucosal Th1-type immune responses in aged mice
2001
|
|
| 2001
|
The NALT mucosal immune system is not impaired in aged mice
2001
|
|
| 2001
|
Oral tolerance revisited: Prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses
2001
|
|
| 2001
|
Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies
2001
|
|
| 2001
|
Peyer's patches are required for oral tolerance to proteins
2001
|
|
| 2000
|
Evidence for early aging in the mucosal immune system. (vol 165, pg 5352, 2000)
2000
|
|
| 2000
|
Evidence for early aging in the mucosal immune system
2000
|
|
| 2000
|
Enterotoxin adjuvants have direct effects on T cells and antigen- presenting cells that result in either interleukin-4-dependent or - independent immune responses
2000
|
|
| 2000
|
Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis
2000
|
|
| 2000
|
Alternate mucosal immune system: Organized Peyer's patches are not required for IgA responses in the gastrointestinal tract
2000
|
|
| 2000
|
Aberrant mucosal immunity in aged mice is due to T cell dysregulation
2000
|
|
| 2000
|
Abrogation of lymphotoxin-beta receptor signal pathway inhibits colonic patch genesis and Th2-type colitis
2000
|
|
| 2000
|
An alternate mucosal immune system: Organized Peyer's patches are not required for gastrointestinal IgA responses.
2000
|
|
| 2000
|
Both mucosal and systemic lymphocytes contribute to mammary gland development in maternal immunity
2000
|
|
| 2000
|
Host response to experimental vaginal candidiasis in delta-chain TCR knock-out mice
2000
|
|
| 2000
|
Oral tolerance blocks cholera toxin induced IgA responses
2000
|
|
| 2000
|
Mucosal vaccination and immune responses in the elderly
2000
|
|
| 2000
|
Correlation between salivary IgA response and colonization of Streptococcus mutans.
2000
|
|
| 2000
|
Human nasopharyngeal-associated lymphoreticular tissues: Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils
2000
|
|
| 2000
|
Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis
2000
|
|
| 1999
|
Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response
1999
|
|
| 1999
|
gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion.
1999
|
|
| 1999
|
Human interleukin-12 enhances interferon-γ-producing influenza-specific memory CD8+ cytotoxic T lymphocytes
1999
|
|
| 1999
|
Effects of intranasal immunization on protective immunity against otitis media
1999
|
|
| 1999
|
Partial IgA-deficiency with increased Th2-type cytokines in TGF-β1 knockout mice
1999
|
|
| 1999
|
Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity
1999
|
|
| 1999
|
Mucosal Th1- versus Th2-type responses for antibody- or cell-mediated immunity to simian immunodeficiency virus in rhesus macaques
1999
|
|
| 1999
|
Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses
1999
|
|
| 1999
|
Strategies for mucosal vaccine development
1999
|
|
| 1999
|
Strategies for mucosal vaccine development.
1999
|
|
| 1999
|
Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions
1999
|
|
| 1999
|
γδ T cells regulate mucosally induced tolerance in a dose-dependent fashion
1999
|
|
| 1998
|
2.4 Measuring Cytokine Responses by ELISA, ELISPOT and RT-PCR Methods
1998
|
|
| 1998
|
Nasal immunization of nonhuman primates with simian immunodeficiency virus p55(gag) and cholera toxin adjuvant induces Th1/Th2 help for virus- specific immune responses in reproductive tissues
1998
|
|
| 1998
|
Immune Responses against Outer Membrane Protein P6 of Nontypeable Haemophilus influenzae
1998
|
|
| 1998
|
Human milk proteins including secretory IgA fail to elicit tolerance after feeding
1998
|
|
| 1998
|
Organized Peyer's patches are not required for mucosal IgA responses in the gut of LTβR-Ig treated mice
1998
|
|
| 1998
|
The CD40-CD40L signal pathway is essential for mucosally-induced tolerance.
1998
|
|
| 1998
|
Trinitrobenzene sulfonic acid (TNBS) induced colitis in IFN-gamma deficient mice.
1998
|
|
| 1998
|
gamma delta T cells are not essential for the establishment of mucosally-induced high dose tolerance
1998
|
|
| 1998
|
A mucosal intranet: Intestinal Epithelial cells down-regulate intraepithelial, but not peripheral, T lymphocytes
1998
|
|
| 1998
|
Lack of orally induced systemic unresponsiveness in IFN-γ knockout mice
1998
|
|
| 1998
|
Induction of Th2 cytokine expression for p27-specific IgA B cell responses after targeted lymph node immunization with simian immunodeficiency virus antigens in rhesus macaques
1998
|
|
| 1998
|
Inflammatory mediators of the terminal dentition in adult and early onset periodontitis
1998
|
|
| 1998
|
Intraepithelial lymphocytes from villus tip and crypt portions of the murine small intestine show distinct characteristics
1998
|
|
| 1998
|
Measuring cytokine responses by ELISA, ELISPOT and RT-PCR methods
1998
|
|
| 1997
|
A novel alkaline phosphatase-based isolation method allows characterization of intraepithelial lymphocytes from villi tip and crypt regions of murine small intestine
1997
|
|
| 1997
|
Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates
1997
|
|
| 1997
|
A T cell/B cell/epithelial cell internet for mucosal inflammation and immunity
1997
|
|
| 1997
|
An interleukin-7 internet for intestinal intraepithelial T cell development: Knockout of ligand or receptor reveal differences in the immunodeficient state
1997
|
|
| 1997
|
A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity
1997
|
|
| 1997
|
Functional γδ t-lymphocyte defect associated with human immunodeficiency virus infections
1997
|
|
| 1997
|
Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity
1997
|
|
| 1997
|
A nontoxic mutant of cholera toxin elicits mucosal immunity to vaccines given intranasally.
1997
|
|
| 1997
|
Complete deficiency of intraepithelial gamma delta T cell development in IL-7R(-/-) but not IL-7(-/-) mice.
1997
|
|
| 1997
|
Helper T subsets and cytokines for mucosal immunity and tolerance.
1997
|
|
| 1997
|
Intranasal combined SIV vaccine induces both Th1 and Th2 responses in mucosal tissues of rhesus macaques.
1997
|
|
| 1997
|
Molecular and cellular mechanisms for periodontal diseases: Role of Th1 and Th2 type cytokines in induction of mucosal inflammation
1997
|
|
| 1997
|
Molecular and cellular mechanisms for periodontal diseases: Role of Th1 and Th2 type cytokines in induction of mucosal inflammation
1997
|
|
| 1997
|
Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation.
1997
|
|
| 1997
|
Oral recombinant Salmonella elicits mucosal IgA responses but accelerates colitis in IL-10 knockout mice.
1997
|
|
| 1996
|
Absence of oral tolerance to human milk proteins (HMP) in mice
1996
|
|
| 1996
|
Comparison of intraepithelial CD8+ and double negative (DN), yst cells for tel and tc2 cytokine synthesis
1996
|
|
| 1996
|
Impaired mucosal iga responses in tcr6-/- mice
1996
|
|
| 1996
|
Mode of vaccine expression by salmonella dictates th cell response: Th2 cell precedes TH1 cell antienterotoxigenic e. coli (ETEC) fimbriae responses
1996
|
|
| 1996
|
Mucosal immune responses in CD4 knockout mice
1996
|
|
| 1996
|
Mucosally induced tolerance in IL-4-/- but not IFN-γ-/MICE
1996
|
|
| 1996
|
Mutants of cholera toxin lacking cyclic-AMP activity retain adjuvanticity
1996
|
|
| 1996
|
Prophylactic and therapeutic effects of oral and intranasal immunization of bovine type II collagen (CII) on collagen-induced-arthritis (cia) in DBA/1J mice
1996
|
|
| 1996
|
Systemically administrated cholera toxin (ct) induced iga responses in rhesus macaqueS
1996
|
|
| 1996
|
Tip and crypt intestinal epithelial cells express different levels of cd80 and cd86 molecules
1996
|
|
| 1996
|
Hapten-Induced Model of Murine Inflammatory Bowel Disease: Mucosal Immune Responses and Protection by Tolerance
1996
|
|
| 1996
|
Oral immunization with simian immunodeficiency virus (SIV) gag p55 and cholera toxin (CT) elicits mucosal immune responses in non-human primates.
1996
|
|
| 1996
|
Luminometry: A novel bioluminescent immunoassay enhances the quantitation of mucosal and systemic antibody responses
1996
|
|
| 1996
|
Interleukin 2 (IL-2) and interleukin 7 (IL-7) reciprocally induce IL-7 and IL-2 receptors on γδ T-cell receptor-positive intraepithelial lymphocytes
1996
|
|
| 1996
|
Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine
1996
|
|
| 1996
|
gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses.
1996
|
|
| 1996
|
γ/δ T cell-deficient mice have impaired mucosal immunoglobulin a responses
1996
|
|
| 1996
|
Selected Th1 and Th2 cytokine mRNA expression by CD4+ T cells isolated from inflamed human gingival tissues
1996
|
|
| 1996
|
Mucosal immunity: Regulation by helper T cells and a novel method for detection
1996
|
|
| 1996
|
Absence of exogenous interleukin-4-induced apoptosis of gingival macrophages may contribute to chronic inflammation in periodontal diseases
1996
|
|
| 1996
|
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin
1996
|
|
| 1996
|
Role of γδ T cells in the regulation of mucosal IgA response and oral tolerance
1996
|
|
| 1996
|
The role of Th1 and Th2 cells for mucosal IgA responses
1996
|
|
| 1995
|
Analysis of intestinal intraepithelial lymphocyte (IEL) T cells in mice expressing anti-CD8 immunoglobulin transgenes
1995
|
|
| 1995
|
ENHANCED DETECTION OF MUCOSAL AND SYSTEMIC IMMUNE-RESPONSES EMPLOYING BIOLUMINESCENT IMMUNOCHEMICAL PROBES
1995
|
|
| 1995
|
FUNCTIONAL AND PHENOTYPIC CHARACTERIZATION OF INFLUENZA VIRUS-SPECIFIC CD8+/CD45R0+ CTLS AND CORRELATION WITH IFN-GAMMA PRODUCTION
1995
|
|
| 1995
|
INDUCTION AND REGULATION OF IMMUNE-RESPONSES TO BIOENGINEERED MUCOSAL VACCINES
1995
|
|
| 1995
|
Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine
1995
|
|
| 1995
|
Ig-Secreting and interferon-γ-producing cells in mice mucosally immunized with influenza virus
1995
|
|
| 1995
|
Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4
1995
|
|
| 1995
|
Polarized Th2 cytokine expression by both mucosal γδ and αβ T cells
1995
|
|
| 1994
|
TNBS-SPECIFIC ORAL TOLERANCE PROTECTS FROM HAPTEN-INDUCED COLITIS
1994
|
|
| 1994
|
CYTOKINE PRODUCING T-CELLS IN IGA EFFECTOR TISSUES - SYNTHESIS OF IL-5 AND IL-6 BY GAMMA-DELTA TCR+ T-CELLS IN SALIVARY-GLAND
1994
|
|
| 1994
|
CYTOKINE PRODUCTION AND CD45 ISOFORM EXPRESSION BY CD8+ T-CELLS ISOLATED FROM SIV-INFECTED RHESUS MACAQUES
1994
|
|
| 1994
|
IL-2 RECEPTOR AND SIGNAL-TRANSDUCTION IN GAMMA-DELTA-TCR+ INTRAEPITHELIAL LYMPHOCYTES (IELS)
1994
|
|
| 1994
|
T-CELL POPULATIONS ALONG THE RESPIRATORY-TRACT OF BALB/C MICE
1994
|
|
| 1994
|
THE EFFECT OF EPITHELIAL-CELLS ON THE ACTIVATION OF CD3+ IELS
1994
|
|
| 1994
|
CHARACTERIZATION OF VIRGIN AND MEMORY TYPE IFN-GAMMA PRODUCING CD8(+) T-LYMPHOCYTES IN SIV-INFECTED RHESUS MACAQUES
1994
|
|
| 1994
|
Characterization of cytokine‐producing cells in mucosal effector sites: CD3+ T cells of Th1 and Th2 type in salivary gland‐associated tissues
1994
|
|
| 1994
|
Cytokine synthesis and apoptosis by intestinal intraepithelial lymphocytes: Signaling of high density αβ T cell receptor+ and γδ T cell receptor+ T cells via T cell receptor‐CD3 complex results in interferon‐γ and interleukin‐5 production, while low density T cells undergo DNA fragmentation
1994
|
|
| 1994
|
Function of αbeta; TCR+ and γdelta; TCR+ IELs for the gastrointestinal immune response
1994
|
|
| 1994
|
Function of αβ TCR+ and γδ TCR + IELs for the Gastrointestinal Immune Response
1994
|
|
| 1994
|
Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin
1994
|
|
| 1994
|
IL-4 INDUCES APOPTOSIS IN MACROPHAGES ISOLATED FROM INFLAMED GINGIVAL TISSUES
1994
|
|
| 1994
|
Quantitation of human influenza virus-specific cytotoxic T lymphocytes: Correlation of cytotoxicity and increased numbers of IFN-γ producing CD8+ T cells
1994
|
|
| 1994
|
TYPE-1 TYPE-2 CYTOKINE PRODUCTION BY CD4+ T-CELLS IN ADULT PERIODONTITIS
1994
|
|
| 1994
|
The common mucosal immune system: From basic principles to enteric vaccines with relevance for the female reproductive tract
1994
|
|
| 1993
|
alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
1993
|
|
| 1993
|
Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4
1993
|
|
| 1993
|
Function of αβ TCR+ intestinal intraepithelial lymphocytes: Th1-and Th2-type cytokine production by CD4+ CD8- and CD4+ CD8+ T cells for helper activity
1993
|
|
| 1993
|
Characterization of t and b cells isolated from mucosa-associated tissues of the rhesus macaque
1993
|
|
| 1993
|
Helper t cell subsets for immunoglobulin a responses: Oral inmaunization with tetanus toxoid and cholera toxinn as adjuvant selectively induces th2 cells in mucosa associated tissues
1993
|
|
| 1993
|
MUCOSAL VACCINE FOR AIDS - ORAL IMMUNIZATION WITH HIV GP120 IN COMBINATION WITH LIPOSOME AND CHOLERA-TOXIN INDUCES ANTIGEN-SPECIFIC IGA PRODUCING CELLS
1993
|
|
| 1993
|
NEW PERSPECTIVES IN MUCOSAL IMMUNITY WITH EMPHASIS ON VACCINE DEVELOPMENT
1993
|
|
| 1993
|
New perspectives in mucosal immunity with emphasis on vaccine development.
1993
|
|
| 1993
|
Cytokines and periodontal disease: immunopathological role of interleukins for B cell responses in chronic inflamed gingival tissues.
1993
|
|
| 1993
|
A SUBSET OF GAMMA-DELTA-TCR+ INTRAEPITHELIAL LYMPHOCYTES (IELS) NATURALLY EXPRESS BOTH IL-2 AND IL-7 RECEPTORS
1993
|
|
| 1993
|
CHARACTERIZATION T-CELL SUBSETS IN MURINE TRACHEAL INTRAEPITHELIAL LYMPHOCYTES (IELS)
1993
|
|
| 1993
|
COMPARATIVE-ANALYSIS OF CYTOKINE SECRETION BY LAMINA PROPRIA LYMPHOCYTES (LPLS) FROM THE MOUSE SMALL AND LARGE-INTESTINE
1993
|
|
| 1993
|
CYTOKINE PRODUCTION IN IGA EFFECTOR SITES - SALIVARY-GLAND GAMMA/DELTA-TCR+ AND ALPHA/BETA-TCR+ T-CELLS SECRETE TYPE-2 LYMPHOKINES
1993
|
|
| 1993
|
EFFECT OF EXPRESSION OF ANTI-CD8 AS TRANSGENE ON MUCOSAL LYMPHOCYTES
1993
|
|
| 1993
|
INDUCTION OF PROTECTIVE IMMUNE-RESPONSES TO ORALLY-ADMINISTERED TETANUS TOXOID (TT) USING CHOLERA-TOXIN (CT) AS AN ADJUVANT
1993
|
|
| 1993
|
QUANTITATION OF HUMAN INFLUENZA-SPECIFIC CTLS - CORRELATION OF CYTOTOXICITY AND INCREASED NUMBERS OF IFN-GAMMA PRODUCING CD8+ T-CELLS
1993
|
|
| 1993
|
SIGNALING OF LOW-DENSITY ALPHA/BETA-TCR+ AND GAMMA/DELTA-TCR+ IELS VIA THE TCR-CD3 COMPLEX LEADS TO APOPTOSIS
1993
|
|
| 1993
|
Cytokine-specific ELISPOT assay single cell analysis of IL-2, IL-4 and IL-6 producing cells
1993
|
|
| 1993
|
CYTOKINE SECRETION BY INTRAEPITHELIAL (IEL) AND LAMINA PROPRIA LYMPHOCYTES (LPL) FROM MURINE SMALL-BOWEL (SB) AND LARGE-BOWEL (LB)
1993
|
|
| 1993
|
Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: Consequences of CD4+ and CD8+ T cell depletion
1993
|
|
| 1993
|
Cytokine synthesis by intestinal intraepithelial lymphocytes: Both γ/δ T cell receptor-positive and α/β T cell receptor-positive T cells in the G1 phase of cell cycle produce IFN-γ and IL-5
1993
|
|
| 1993
|
Optimizing oral vaccines: Induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant
1993
|
|
| 1993
|
The Mycobacterium tuberculosis 71‐kDa heat‐shock protein induces proliferation and cytokine secretion by murine gut intraepithelial lymphocytes
1993
|
|
| 1993
|
αβ T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2- like function for B cell responses
1993
|
|
| 1992
|
Cytokine production and T cell receptor expression by salivary gland T cells and intraepithelial T lymphocytes for the regulation of the IgA response
1992
|
|
| 1992
|
Induction of T helper cells and cytokines for mucosal IgA responses
1992
|
|
| 1992
|
Effects of the Ipr/lpr mutation on T and B cell populations in the lamina propria of the small intestine, a mucosal effector site
1992
|
|
| 1992
|
Immunoregulatory functions for murine htraepithelial lymphocytes: γ/δ T cell receptor-positive (TCR+) T cells abrogate oral tolerance, while α/β TCR+ T cells provide B cell help
1992
|
|
| 1992
|
ACTIVATION OF HIGH-DENSITY ALPHA/BETA-TCR+ IELS VIA THE TCR-CD3 COMPLEX RESULTS IN CYTOKINE PRODUCTION
1992
|
|
| 1992
|
CHARACTERIZATION OF RHESUS MACAQUE TCR-CD3 SPECIFIC MONOCLONAL-ANTIBODIES
1992
|
|
| 1992
|
MODIFICATION OF THE EXPRESSION OF ASIALOGLYCOPROTEIN RECEPTOR ON HUMAN HEPATOMA-CELLS BY CYTOKINES
1992
|
|
| 1992
|
Effects of IL6 on B cells in mucosal immune response and inflammation
1992
|
|
| 1992
|
Immunoregulatory functions for murine intraepithelial lymphocytes: γδ T cell receptor-positive (TCR^+) T cells abrogate oral tolerance, while αβ TCR^+ T cells provide B cell help
1992
|
|
| 1992
|
Intestinal intraepithelial lymphocyte T cells are resistant to Ipr gene‐induced T cell abnormalities
1992
|
|
| 1992
|
Regulation of mucosal immune responses by T lymphocytes: The effect of chronic CD4+T cell deficiency on IgA synthesis
1992
|
|
| 1992
|
The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens
1992
|
|
| 1991
|
Regulatory functions for murine intraepithelial lymphocytes in mucosal responses
1991
|
|
| 1991
|
Role of IL-6 in human antigen-specific and polyclonal IgA responses
1991
|
|
| 1991
|
Role of interleukin-6 in human and mouse mucosal IgA plasma cell responses
1991
|
|
| 1991
|
CYTOKINE PRODUCTION BY TCR1+ T-CELLS - A SUBSET OF IELS PRODUCE BOTH IFN-GAMMA AND IL-5
1991
|
|
| 1991
|
CYTOKINE PROFILE OF CD3+ TCR1+ CONTRASUPPRESSOR CELLS IN MURINE IELS
1991
|
|
| 1991
|
LAMINA PROPRIA LYMPHOCYTES (LPL) AND INTRAEPITHELIAL LYMPHOCYTES (IEL) IN MRL IPR IPR MICE ARE NOT AFFECTED BY THE IPR GENE MUTATION
1991
|
|
| 1991
|
RAT IELS CONTAIN A HIGH-FREQUENCY OF CD4+, TCR2+ T-CELLS
1991
|
|
| 1991
|
ANALYSIS OF IGA RESPONSES IN SIV-INFECTED RHESUS MACAQUES
1991
|
|
| 1991
|
Cytokine regulation of localized inflammation: Induction of activated B cells and IL-6-mediated polyclonal IgG and IgA synthesis in inflamed human gingiva
1991
|
|
| 1991
|
Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis
1991
|
|
| 1991
|
Novel function for intestinal intraepithelial lymphocytes: Murine CD3+, γ/δ TCR+ T cells produce IFN-γ and IL-5
1991
|
|
| 1991
|
Recombinant human interleukin 6 (rhIL-6) promotes the terminal differentiation of in vivo-activated human B cells into antibody-secreting cells
1991
|
|
| 1990
|
Interleukin and localized inflammatory disease: Role of IL-6 in polyclonal IgG and IgA responses in adult periodontitis
1990
|
|
| 1990
|
Immunoregulatory confluence: T cells, fc receptors and cytokines for iga immune responses
1990
|
|
| 1990
|
Regulatory function for murine intraepithelial lymphocytes: Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance
1990
|
|
| 1989
|
Immunoregulatory function of CD3+, CD4- and CD8- T cells. γδ T cell receptor-positive T cells from nude mice abrogate oral tolerance
1989
|
|
| 1989
|
Mucosal homeostasis: Role of interleukins, isotype-specific factors and contrasuppression in the iga response
1989
|
|
| 1988
|
Isotype-specific immunoregulation. Systemic antigen induces splenic T contrasuppressor cells which support IgM and IgG subclass but not IgA responses
1988
|
|
| 1988
|
Role of the galt contrasuppressor T cell circuit in isotype-specific immunoregulation.
1988
|
|
| 1988
|
The role of CD3+, CD4-, and CD8- T cells in mucosal immunoregulation
1988
|
|
| 1987
|
Contrasuppressor cells that break oral tolerance are antigen-specific T cells distinct from T helper (L3T4+), T suppressor (Lyt-2+), and B cells
1987
|
|
